FUROID ™️ has invented a process of cell-specific enrichment, genetic engineering, differentiation and disposition of specific cells in engineered tissues. This bioengineered tissue will be inseparably attached to nucleic acid molecular signature combinations that allow to determine authenticity and assist the manufacturing process.
Patented technology pioneered by FUROID ™️ provides cruelty-free, cell-based tissue/hair replication to replace fur and wool farming. This is done to supply cell-based fabrics to all relevant industries, with the added benefit of built-in, DNA-based, anti-counterfeit properties and gene-edited pigmentations for fur, wool and cotton.
”“We represent a major disruption in the fur and wool sectors”, says Maria Zakurnaeva the President and Co-founder of FUROID, ”and by joining the Medace community, we will have the best possible conditions to develop our technology and bring it to the marketplace”.
FUROID™️ will use the state-of-the-art Medace facilities and expert Quality support to further optimize the manufacturing of their cell-based biomaterials. Ultimately, enabling FUROID’s™️ ground-breaking invention to permit cruelty free bioengineering of animal pelts and wool. An added feature and benefit are the anti-counterfeiting measures in the form of molecular signatures. This will guarantee authenticity, provenance, timestamping, and security.
Learn more about FUROID™️ on their website: https://www.furoid.com/